Hyderabad: Bharat Biotech on Tuesday said Covaxin is the only vaccine to have demonstrated 65.2 percent efficacy against the delta variant of COVID-19.The company also announced that the safety and efficacy analysis data from Phase III clinical trials of Covaxin has been peer-reviewed and published...